CoChat
Sign Up
Cited by 717Acute Ischemic Stroke ManagementCerebrovascular and Carotid Artery DiseasesIntracranial Aneurysms: Treatment and Complications

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion

Open access
Tao, Chunrong, Nogueira, Raul G., Zhu, Yuyou, Sun, Jun, Han, Hongxing, Yuan, Guangxiong, Wen, Changming, Zhou, Peiyang, Chen, Wenhuo, Zeng, Guoyong, Li, Yuwen, Ma, Zhengfei, Yu, Chuanqing, Su, Junfeng, Zhou, Zhiming, Chen, Zhongjun, Liao, Geng, Sun, Yaxuan, Ren, Youquan, Zhang, Hui, Chen, Jie, Yue, Xincan, Xiao, Guodong, Wang, Li, Liu, Rui, Liu, Wenhua, Liu, Yong, Wang, Li, Zhang, Chao, Liu, Tianlong, Song, Jianlong, Li, Rui, Xu, Pengfei, Yin, Yamei, Wang, Guoping, Baxter, Blaise, Qureshi, Adnan I., Liu, Xinfeng, Hu, Wei·2022·New England Journal of Medicine
DOI 10.1056/nejmoa2206317
Open this paper in CoChat — free accountOpen PDF

Abstract

BACKGROUND: Data from trials investigating the effects and risks of endovascular thrombectomy for the treatment of stroke due to basilar-artery occlusion are limited. METHODS: We conducted a multicenter, prospective, randomized, controlled trial of endovascular thrombectomy for basilar-artery occlusion at 36 centers in China. Patients were assigned, in a 2:1 ratio, within 12 hours after the estimated time of basilar-artery occlusion to receive endovascular thrombectomy or best medical care (control). The primary outcome was good functional status, defined as a score of 0 to 3 on the modified Rankin scale (range, 0 [no symptoms] to 6 [death]), at 90 days. Secondary outcomes included a modified Rankin scale score of 0 to 2, distribution across the modified Rankin scale score categories, and quality of life. Safety outcomes included symptomatic intracranial hemorrhage at 24 to 72 hours, 90-day mortality, and procedural complications. RESULTS: Of the 507 patients who underwent screening, 340 were in the intention-to-treat population, with 226 assigned to the thrombectomy group and 114 to the control group. Intravenous thrombolysis was used in 31% of the patients in the thrombectomy group and in 34% of those in the control group. Good functional status at 90 days occurred in 104 patients (46%) in the thrombectomy group and in 26 (23%) in the control group (adjusted rate ratio, 2.06; 95% confidence interval [CI], 1.46 to 2.91, P<0.001). Symptomatic intracranial hemorrhage occurred in 12 patients (5%) in the thrombectomy group and in none in the control group. Results for the secondary clinical and imaging outcomes were generally in the same direction as those for the primary outcome. Mortality at 90 days was 37% in the thrombectomy group and 55% in the control group (adjusted risk ratio, 0.66; 95% CI, 0.52 to 0.82). Procedural complications occurred in 14% of the patients in the thrombectomy group, including one death due to arterial perforation. CONCLUSIONS: In a trial involving Chinese patients with basilar-artery occlusion, approximately one third of whom received intravenous thrombolysis, endovascular thrombectomy within 12 hours after stroke onset led to better functional outcomes at 90 days than best medical care but was associated with procedural complications and intracerebral hemorrhage. (Funded by the Program for Innovative Research Team of the First Affiliated Hospital of USTC and others; ATTENTION ClinicalTrials.gov number, NCT04751708.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa2206317

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Since many clinical differences between Western and non-Western populations have been reported, invariance in relevant features across these populations cannot be assumed but should be examined.

    “However, since many clinical differences between Western and non-Western populations have been reported, invariance in relevant features across these populations cannot be assumed but should be examined [3,40–42].”

    From Hasty generalizations and generics in medical research: A systematic review (2024) · cites this paper as [41]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Related

Metadata

Authors
Tao, C., Nogueira, R. G., Zhu, Y., Sun, J., Han, H., Yuan, G., Wen, C., Zhou, P., Chen, W., Zeng, G., Li, Y., Ma, Z., Yu, C., Su, J., Zhou, Z., Chen, Z., Liao, G., Sun, Y., Ren, Y., Zhang, H., Chen, J., Yue, X., Xiao, G., Wang, L., Liu, R., Liu, W., Liu, Y., Wang, L., Zhang, C., Liu, T., Song, J., Li, R., Xu, P., Yin, Y., Wang, G., Baxter, B., Qureshi, A. I., Liu, X., & Hu, W.
Affiliations
  • University of Science and Technology of China (CN)
  • Wannan Medical College (CN)
ORCID
Venue
New England Journal of Medicine
Publisher
Massachusetts Medical Society
Published
2022-10-13
Volume
387
Issue
15
Pages
1361-1372
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
DOI
10.1056/nejmoa2206317
OpenAlex
W4304808118
Cited by
699
References
23
Citations by year
2026: 146 · 2025: 168 · 2024: 201 · 2023: 162 · 2022: 21
FWCI
99.63
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cerebrovascular and Carotid Artery Diseases
  • Health Sciences › Medicine › Clinical Neurology › Intracranial Aneurysms: Treatment and Complications
Keywords
basilar artery occlusion, acute ischemic stroke, intravenous thrombolysis, functional outcome, modified Rankin Scale, symptomatic intracranial hemorrhage, 90-day mortality, procedural complications, Chinese patients, arterial perforation, quality of life
MeSH terms
Arterial Occlusive Diseases, Basilar Artery, Brain Ischemia, Fibrinolytic Agents, Humans, Prospective Studies, Quality of Life, Thrombolytic Therapy, Treatment Outcome, Thrombectomy, Recovery of Function, Intracranial Hemorrhages, Stroke, Endovascular Procedures, Administration, Intravenous

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review